4//SEC Filing
Horizon Pharma plc 4
Accession 0001209191-17-030118
CIK 0001492426operating
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:01 PM ET
Size
13.3 KB
Accession
0001209191-17-030118
Insider Transaction Report
Form 4
Pauli Ronald
Director
Transactions
- Tax Payment
Ordinary Shares
2017-05-03$15.12/sh−3,763$56,897→ 14,030 total(indirect: By Trust) - Award
Stock Option (Right to Buy)
2017-05-03+31,153→ 31,153 totalExercise: $15.12Exp: 2027-05-02→ Ordinary shares (31,153 underlying) - Exercise/Conversion
Ordinary Shares
2017-05-03+13,953→ 17,793 total(indirect: By Trust) - Exercise/Conversion
Restricted Stock Units
2017-05-03−13,953→ 0 total→ Ordinary shares (13,953 underlying) - Award
Restricted Stock Units
2017-05-03+14,054→ 14,054 totalFrom: 2018-05-03→ Ordinary shares (14,054 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.
- [F3]The option vests in 12 equal monthly installments from the date of grant.
Documents
Issuer
Horizon Pharma plc
CIK 0001492426
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001492426
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 6:01 PM ET
- Size
- 13.3 KB